Skip to main content

Table 2 Genotype distributions in colorectal cancer patients and healthy controls

From: Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival

Gene Group Rs number Locus/effect Major homozygote Heterozygote Minor homozygote Total n Hardy-Weinberg p
XRCC1 Patients rs25487 Arg399Gln 253 (G/G) 269 (G/A) 68 (A/A) 590 0.96
  Controls    128 (G/G) 136 (G/A) 36 (A/A) 300 1.0
ERCC1 Patients rs11615 Asn118Asn 237 (T/T) 265 (C/T) 78 (C/C) 580 0.96
  Controls    122 (T/T) 151 (C/T) 27 (C/C) 300 0.12
ERCC2 Patients rs238406 Arg156Arg 178 (C/C) 282 (C/A) 112 (A/A) 572 1.0
  Controls    70 (C/C) 162 (C/A) 65 (A/A) 297 0.29
ERCC2 Patients rs13181 Lys751Gln 219 (A/A) 286 (A/C) 76 (C/C) 581 0.51
  Controls    138 (A/A) 125 (A/C) 31 (C/C) 294 0.94
  1. NOTE- Missing data: XRCC1-rs25487 for 6 patients; ERCC1-rs11615 for 16 patients; ERCC2-rs238406 for 3 controls and 24 patients; ERCC2-rs13181 for 15 patients and 6 controls